139 related articles for article (PubMed ID: 9441166)
1. [Standardized rapid hyposensitization with purified hymenoptera venom in wasp venom allergy. Prospective study of development of tolerance and side-effect profile].
Treudler R; Tebbe B; Orfanos CE
Hautarzt; 1997 Oct; 48(10):734-9. PubMed ID: 9441166
[TBL] [Abstract][Full Text] [Related]
2. [Desensitization of allergy to hymenoptera venoms].
Przybilla B; Ruëff F
Wien Med Wochenschr; 1999; 149(14-15):421-8. PubMed ID: 10584286
[TBL] [Abstract][Full Text] [Related]
3. Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis.
Bernstein JA; Kagen SL; Bernstein DI; Bernstein IL
Ann Allergy; 1994 Nov; 73(5):423-8. PubMed ID: 7978535
[TBL] [Abstract][Full Text] [Related]
4. [Therapy control of specific hymenoptera venom allergy].
Aust W; Wichmann G; Dietz A
Laryngorhinootologie; 2010 Dec; 89(12):725-8. PubMed ID: 21132618
[TBL] [Abstract][Full Text] [Related]
5. Rush immunotherapy for wasp venom allergy seems safe and effective in patients with mastocytosis.
Verburg M; Oldhoff JM; Klemans RJ; Lahey-de Boer A; de Bruin-Weller MS; Röckmann H; Sanders C; Bruijnzeel-Koomen CA; Pasmans SG; Knulst AC
Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):192-6. PubMed ID: 26549336
[TBL] [Abstract][Full Text] [Related]
6. Clustered immunotherapy with Yellow Jacket venom. Evaluation of the influence of time interval on in vivo and in vitro parameters.
Malling HJ; Djurup R; Søndergaard I; Weeke B
Allergy; 1985 Jul; 40(5):373-83. PubMed ID: 4037258
[TBL] [Abstract][Full Text] [Related]
7. Rapid Hymenoptera venom immunotherapy: comparative safety of three protocols.
Birnbaum J; Charpin D; Vervloet D
Clin Exp Allergy; 1993 Mar; 23(3):226-30. PubMed ID: 8472191
[TBL] [Abstract][Full Text] [Related]
8. Hymenoptera venom allergy.
Przybilla B; Ruëff F
J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
[TBL] [Abstract][Full Text] [Related]
9. Mastocytosis and insect venom allergy.
Bonadonna P; Zanotti R; Müller U
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
[TBL] [Abstract][Full Text] [Related]
10. [Rush hyposensitization with Hymenoptera venoms. Tolerance and results of therapy].
Przybilla B; Ring J; Griesshammer B; Braun-Falco O
Dtsch Med Wochenschr; 1987 Mar; 112(11):416-24. PubMed ID: 3816590
[TBL] [Abstract][Full Text] [Related]
11. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
Goldberg A; Confino-Cohen R
J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360
[TBL] [Abstract][Full Text] [Related]
12. Discontinuation of yellow jacket venom immunotherapy: follow-up of 75 patients by means of deliberate sting challenge.
van Halteren HK; van der Linden PW; Burgers JA; Bartelink AK
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):767-70. PubMed ID: 9438484
[TBL] [Abstract][Full Text] [Related]
13. [Results of hyposensitization with bee and wasp venom].
Adolph J; Dehnert I; Fischer JF; Wenz W
Z Erkr Atmungsorgane; 1986; 166(1):119-24. PubMed ID: 3953108
[TBL] [Abstract][Full Text] [Related]
14. Sublingual desensitization in patients with wasp venom allergy: preliminary results.
Patriarca G; Nucera E; Roncallo C; Aruanno A; Lombardo C; Decinti M; Pascolini L; Milani M; Buonomo A; Schiavino D
Int J Immunopathol Pharmacol; 2008; 21(3):669-77. PubMed ID: 18831935
[TBL] [Abstract][Full Text] [Related]
15. Rush hymenoptera venom immunotherapy is efficacious and safe.
Pasaoglu G; Sin BA; Misirligil Z
J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
[TBL] [Abstract][Full Text] [Related]
16. [A modified ultra-rush-protocol of allergen immunotherapy in children and adolescents with insect venom allergy].
Steiss JO; Hüls G; Gortner L; Lindemann H
Klin Padiatr; 2004; 216(2):79-82. PubMed ID: 15106079
[TBL] [Abstract][Full Text] [Related]
17. Venom immunotherapy: tolerance to a 3-day protocol of rush-immunotherapy.
Díez Gómez ML; Quirce Gancedo S; Juliá de Páramo B
Allergol Immunopathol (Madr); 1995; 23(6):277-84. PubMed ID: 8579006
[TBL] [Abstract][Full Text] [Related]
18. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.
Gorska L; Chelminska M; Kuziemski K; Skrzypski M; Niedoszytko M; Damps-Konstanska I; Szymanowska A; Siemińska A; Wajda B; Drozdowska A; Jutel M; Jassem E
Int Arch Allergy Immunol; 2008; 147(3):241-5. PubMed ID: 18594155
[TBL] [Abstract][Full Text] [Related]
19. Safety of rush insect venom immunotherapy. The results of a retrospective study in 178 patients.
Wenzel J; Meissner-Kraemer M; Bauer R; Bieber T; Gerdsen R
Allergy; 2003 Nov; 58(11):1176-9. PubMed ID: 14616130
[TBL] [Abstract][Full Text] [Related]
20. Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients.
Sturm G; Kränke B; Rudolph C; Aberer W
J Allergy Clin Immunol; 2002 Dec; 110(6):928-33. PubMed ID: 12464961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
